2m 2m 2m 2m 2m 2m 2m
Nexien BioPharma (NXEN)
OTC
$0.0001$0.00 (0.00%)
Price as of Jun 01, 2026- $7,077.00Market Cap
- -98.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Nexien BioPharma (NXEN)
$0.0001$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 31
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0001
$0.0001
$0.0001
1-Year Range
$0.0001
$0.01
$0.0001
Latest Close$0.0001
Change
$0.00 (0.00%)
Volume500
Market Cap$7,077.00
Shares Outstanding70.8M
P/E (TTM)-0.04
Diluted EPS (TTM)-$0.003
Enterprise Value$158,792.00
Information as of 06/01/2026
Company Profile
NEXIEN BIOPHARMA, INC.
https://www.nexienbiopharma.com$7,077.00
Market Cap
-$188,082.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
4340 East Kentucky Avenue, Glendale, CO, United States, 80246
303 495 7583Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
Key Executives
- Robert I. Goldfarb
- Evan L. Wasoff
- Richard S. Greenberg
Current Ownership Distribution
- Insiders89.5M (37.80%)
- Institutions83.2M (35.11%)
- Mutual Funds64.2M (27.09%)
- Other0 (0.00%)